Device Lynx_uro

Lynx System

Payments companies reported to CMS as associated with Lynx System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$8,713associated payments (2023-2025)
150clinicians with associated payments
1company reporting

By year

2023 $2,718
2024 $4,227
2025 $1,768

Payments reported as associated with Lynx System, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Urology $3,737
Urogynecology and Reconstructive Pelvic Surgery (Urology) $1,184
Obstetrics & Gynecology $991
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) $760
Physician Assistant $294
Family $255

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Lynx System

These are the largest totals companies reported as associated with Lynx System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Kevin Sumsion Layton, UT Obstetrics & Gynecology $429.23
Elias Hsu Denver, CO Urology $375.30
Anjali Kapur East Brunswick, NJ Urogynecology and Reconstructive Pelvic Surgery (Urology) $295.30
Sandip Vasavada Cleveland, OH Urology $292.90
Jarin Leavitt Layton, UT Obstetrics & Gynecology $257.75
Gina Cliett Oro Valley, AZ Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) $159.39
Ly Hoang Roberts Cleveland, OH Urogynecology and Reconstructive Pelvic Surgery (Urology) $158.25
Kevin Gioia Rumson, NJ Urology $147.65
Justina Tam Stony Brook, NY Urogynecology and Reconstructive Pelvic Surgery (Urology) $147.65
Bradley Garden Coral Springs, FL Urology $147.65

Prescribed Lynx System?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.